(NasdaqGM:MNOV),(TSE:4875.T),(TSE:4875), LA JOLLA, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announces the completion of patient enrollment in its Phase 2 clinical trial, MN-001-NATG-202, evaluating MN-001 (Tipelukast) for the treatment of […]

(NASDAQ:TSHA), TSHA-102 granted Breakthrough Therapy designation by FDA Finalized FDA alignment on REVEAL pivotal trial protocol and SAP, including 6-month interim analysis that may expedite BLA submission, which was enabled by the rigorous developmental milestone evaluation in Part A REVEAL Phase 1/2 trials showing an unprecedented response rate Dosing of first patient in REVEAL pivotal

(NASDAQ:SNDL),(CNSX:SNDL), EDMONTON, Alberta, Nov. 04, 2025 (GLOBE NEWSWIRE) — SNDL Inc. (NASDAQ: SNDL, CSE: SNDL) (“SNDL” or the “Company“) reported its financial and operational results for the third quarter ended September 30, 2025. All financial information in this press release is reported in millions of Canadian dollars unless otherwise indicated. SNDL has also posted a

(NasdaqGM:AQST),(NASDAQ:TLSA), Changes strategically aligned to support planned launch of Anaphylm(TM) (dibutepinephrine) Sublingual Film, if approved by the FDA, and to accelerate the Company's ongoing development initiatives Matthew Davis, M.D., RPh will join immediately as Chief Development Officer Gary Slatko, M.D., M.B.A, will become interim Chief Medical Officer Peter Boyd, M.B.A, has been promoted to Chief

(NASDAQ:FWRG), Same-restaurant sales growth of 7.1%Total revenues increased 25.6%Net income of $3.0 million and Adjusted EBITDA of $34.1 million21 new system-wide restaurants opened in 14 states BRADENTON, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) — First Watch Restaurant Group, Inc. (NASDAQ: FWRG) (“First Watch” or the “Company”), the leading Daytime Dining concept serving breakfast, brunch and

MONTREAL, Nov. 04, 2025 (GLOBE NEWSWIRE) — Moisson Montreal is proud to announce that it has been named one of Canada's Top 10 Most Impactful Food Banks by Charity Intelligence (Ci), an independent organization that evaluates the impact of Canadian charities. This recognition highlights the efficiency of Moisson Montreal's operations and the social reach of

(NasdaqGM:DAVE), Record Q3 Revenue of $150.8 Million, up 63% Y/Y Driven by Accelerating MTM Growth and Record ARPU Record Q3 ExtraCash Monetization Rate Net of Losses of 4.8%, up 45bps Y/Y as Originations Grew 49% to over $2 Billion; Improving Credit Performance Supported Further Net Monetization Rate Expansion Q/Q Record Profitability–Net Income hits $92.0 Million;

(NASDAQ:TLRY),(TSX:TLRY), LEAMINGTON, Ontario, Nov. 04, 2025 (GLOBE NEWSWIRE) — Tilray Medical a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, today announced significant updates to its Tilray Medical pricing programs in

(NASDAQ:CRVO), FDA feedback enables CervoMed to proceed with proposed endpoints, patient enrichment strategy, and other key aspects of Phase 3 trial design to support potential New Drug Application CervoMed is advancing preparations for global pivotal trial initiation in the second half of 2026 BOSTON, Nov. 04, 2025 (GLOBE NEWSWIRE) — CervoMed Inc. (NASDAQ: CRVO) (CervoMed

(NASDAQ:AXGN), ALACHUA, Fla. and TAMPA, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that management is scheduled to participate in three upcoming investor conferences: Jefferies Global Healthcare Conference (London)Participation: Fireside chat and 1×1